Unconjugated Human CD47 Protein, His,Avitag™ (HPLC verified)

Customer Reviews
Cat. No. / Size
Price
Qty
CD7-HA2E9-50ug
$270.00
CD7-HA2E9-1mg (500ug X 2)
$2745.00
ETA of in-stock products:2 business days

Product Details

  • Synonyms

    CD47, MER6, IAP, OA3

  • Source

    Unconjugated Human CD47, His,Avitag (CD7-HA2E9) is expressed from human 293 cells (HEK293). It contains AA Gln 19 - Pro 139 (Accession # Q08722-3).

    Predicted N-terminus: Gln 19

    Request for sequence
  • Molecular Characterization

    CD47 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag™).

    The protein has a calculated MW of 16.9 kDa. The protein migrates as 33-40 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Application

    CD7-HA2E9 is the unconjugated version of CD7-H82E9 (Biotinylated Human CD47, His,Avitag). It can be utilized for assay development or customized biotinylation according to the experimental designs.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Purity

    >95% as determined by SDS-PAGE.

    >90% as determined by SEC-HPLC.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in 10 mM Bicine, pH8.3 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SDS-PAGE

    CD47 SDS-PAGE

    Unconjugated Human CD47, His,Avitag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-HPLC

    CD47 SEC-HPLC

    The purity of Unconjugated Human CD47, His,Avitag (Cat. No. CD7-HA2E9) was greater than 90% as determined by SEC-HPLC.

  • Bioactivity-ELISA

     CD47 ELISA

    Immobilized Human SIRP alpha, Fc Tag (Cat. No. SIA-H5251) at 2 μg/mL (100 μL/well) can bind Unconjugated Human CD47, His,Avitag (Cat. No. CD7-HA2E9) with a linear range of 2-13 ng/mL (QC tested).

    Protocol
  •  CD47 ELISA

    Immobilized Unconjugated Human CD47, His,Avitag (Cat. No. CD7-HA2E9) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Human CD47 Antibody, Human IgG4 with a linear range of 0.06-4 ng/mL (QC tested).

    Protocol

Customer Reviews
Writing Reviews

  • 1***62019-10-12
    Likes
    I used this protein to detect mouse serum titer. The product is more cost-effective, good quality, and the obtained data is highly reliable compared to RnD Systems products. In addition, when I performed other ELISA experiments, the data was greatly reproducible.

Background

Leukocyte surface antigen CD47 is also known as Antigenic surface determinant protein OA3, Integrin-associated protein (IAP) and Protein MER6. CD47 contains 1 Ig-like V-type (immunoglobulin-like) domain. CD47 is very broadly distributed on normal adult tissues. CD47 has a role in both cell adhesion by acting as an adhesion receptor for THBS1 on platelets, and in the modulation of integrins and plays an important role in memory formation and synaptic plasticity in the hippocampus by similarity. CD47 is the receptor for SIRPA, binding to which prevents maturation of immature dendritic cells and inhibits cytokine production by mature dendritic cells. CD47 Interaction with SIRPG mediates cell-cell adhesion, enhances superantigen-dependent T-cell-mediated proliferation and costimulates T-cell activation.

Recent Advances

 
Drug Development Progress
  • English Name:

    Cluster of differentiation 47

  • Category:

  • Approved Drugs:

    0 Details

  • Drugs in Clinical Trials:

    53 Details

  • Highest Development Stage:

    Phase 3 Clinical

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background